PT - JOURNAL ARTICLE AU - Ng, Ta-Chou AU - Cheng, Hao-Yuan AU - Chang, Hsiao-Han AU - Liu, Cheng-Chieh AU - Yang, Chih-Chi AU - Jian, Shu-Wan AU - Liu, Ding-Ping AU - Cohen, Ted AU - Lin, Hsien-Ho TI - Effects of case- and population-based COVID-19 interventions in Taiwan AID - 10.1101/2020.08.17.20176255 DP - 2020 Jan 01 TA - medRxiv PG - 2020.08.17.20176255 4099 - http://medrxiv.org/content/early/2020/08/19/2020.08.17.20176255.short 4100 - http://medrxiv.org/content/early/2020/08/19/2020.08.17.20176255.full AB - In the first wave of the COVID-19 pandemic, broad usage of non-pharmaceutical interventions played a crucial role in controlling epidemics1–6. However, the substantial economic and societal costs of continuous use of border controls, travel restrictions, and physical distancing measures suggest that these measures may not be sustainable and that policymakers have to seek strategies to lift the restrictions. Taiwan was one of the few countries that demonstrated initial success in eliminating the COVID-19 outbreak without strict lockdown or school closure. To understand the key contributors to the successful control, we applied a stochastic branching model to empirical case data to evaluate and compare the effectiveness of more targeted case-based (including contact tracing and quarantine) and less targeted population-based interventions (including social distancing and face mask use) in Taiwan. We found that case-based interventions alone would not be sufficient to contain the epidemic, even in a setting where a highly efficient contact tracing program was in place. The voluntary population-based interventions have reduced the reproduction numbers by more than 60% and have likely played a critical role at the early stage of the outbreak. Our analysis of Taiwan’s success highlights that coordinated efforts from both the government and the citizens are indispensable in the fight against COVID-19 pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by Taiwan Ministry of Science and Technology (MOST 109-2628-B-002-022-, and MOST 109-2628-B-002-031-). The funder of this study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:There is no need for IRB approval for this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.